Primerica (PRI)

NYSE Financials Life & Health Insurance S&P MidCap 400
$290.58
+1.62 (+0.56%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+3.4%
1M+5.5%
3M-7.3%
6M+5.8%
YTD+12.5%
1Y+13.8%
3Y+49.5%
5Y+72.7%

Key statistics

Full financials →
Market cap$8.8B
P/E (TTM)11.5
EPS (TTM, diluted)$25.30
P/S2.52
P/B3.12
EV / EBITDA—
Revenue (TTM)$3.49B
Revenue growth+8.3%
Net margin22.8%
ROE28.2%
Debt / equity0.13
FCF yield11.1%
Dividend yield1.60%
Payout ratio18%
Beta (1Y)0.16
Volatility (1Y)20.8%
52-week range$230.09 – $327.28
Avg volume (50D)196.62K

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Head and Shoulders (weekly)

Forming
PRI Head and Shoulders chart

Trigger $252.63 (-13.1% away). Details →

Nov 4, 4:32 PM ET

Primerica Q3 net income rises 1% to $209 million; diluted EPS up 6% to $6.76

Positive earnings 2.027.01

Primerica reported third-quarter 2026 results for the period ended September 30, 2026, with total revenues of $902 million, up 7% year over year, and net income of $209 million, up 1%. Diluted EPS of $6.76 rose 6%, and diluted adjusted operating EPS of $6.77 rose 7%, with the company also declaring a $1.20 per share dividend.

  • Total revenues of $902 million rose 7% from the third quarter of 2025
  • Investment and Savings Products sales rose 19% to $4.4 billion; Term Life adjusted operating income before income taxes fell 12%
  • Company returned $159 million to stockholders in the quarter, including $122 million of share repurchases
  • Board approved a $1.20 per share dividend payable December 14, 2026 to holders of record on November 20, 2026
Read the filing on SEC.gov ↗
Aug 5, 4:29 PM ET

Primerica Q2 2026 net income rises 13% to $202 million; diluted EPS up 19% to $6.45

Positive earnings Written later 2.027.01

Primerica reported second-quarter 2026 results, with total revenues of $865 million up 9% and net income of $202 million up 13% from a year earlier. Diluted EPS rose 19% to $6.45 and adjusted operating EPS rose 17% to $6.41. Term Life adjusted pre-tax income fell 4%, while the Investment and Savings Products segment's pre-tax income rose 31%.

  • Total revenues $865 million, up 9%; net income $202 million, up 13%
  • Diluted EPS $6.45, up 19%; diluted adjusted operating EPS $6.41, up 17%
  • Investment and Savings Products sales rose 23% to $4.4 billion; Term Life policies issued fell 12% to 78,904
  • Company repurchased $135 million of common stock and declared a $1.20 per share dividend payable September 14, 2026
Read the filing on SEC.gov ↗
Jun 2, 4:29 PM ET

Primerica extends $200 million revolving credit facility to June 2, 2031

Neutral financing Written later 1.012.03

On June 2, 2026, Primerica amended and restated its $200 million unsecured revolving credit facility, which was scheduled to expire on June 22, 2026. The amendment extends the maturity to June 2, 2031, modifies the Applicable Margin and adjusts certain financial covenants. No amounts were outstanding when the agreement was signed, and no amounts had been drawn as of the report date.

  • Facility size remains $200 million; maturity extended from June 22, 2026 to June 2, 2031
  • Lenders include The Bank of New York Mellon, Citibank, N.A., JP Morgan Chase Bank, N.A., Royal Bank of Canada, The Bank of Nova Scotia and Wells Fargo Bank, National Association
  • SOFR loan margins range from 1.00% to 1.625% per annum; commitment fee ranges from 0.08% to 0.225% of the unused portion, both set by the company's Debt Rating
  • No amounts have been drawn; proceeds may be used for general corporate purposes
Read the filing on SEC.gov ↗
May 6, 4:18 PM ET

Primerica Q1 2026 EPS rises 18% to $5.97 on record $4.3 billion investment sales

Positive earnings Written later 2.027.01

Primerica reported first-quarter 2026 results on May 6, 2026, with total revenues of $872.7 million (up 8%) and net income of $190.1 million (up 12%). Diluted EPS of $5.97 rose 18%, and diluted adjusted operating EPS of $5.96 rose 19%, driven mainly by record Investment and Savings Products sales, while life-licensed recruiting and new term life policies declined.

  • Investment and Savings Products sales were a record $4.3 billion, up 22%, and average client asset values were $129.9 billion, up 15%.
  • Recruits fell 17% to 84,217, and the life-licensed sales force totaled 149,732 at March 31, 2026, down 2%.
  • Life insurance policies issued fell 14% to 74,054, and annualized issued term life premium decreased 10% to $83.3 million.
  • The company repurchased $135 million of common stock in the quarter and declared a $1.20 per share dividend payable June 12, 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own PRI

All investors →
InvestorValue% of portfolioLast quarter
Renaissance Technologies $24.65M0.03% Added
Ray Dalio Bridgewater Associates $7.09M0.03% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All PRI congressional trades →
TradedMemberTypeAmount
May 12, 2025Jefferson Shreve IN-06Sell$15,001 – $50,000
Feb 24, 2025Jefferson Shreve IN-06Sell (partial)$15,001 – $50,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from Primerica's SEC XBRL filings. Not investment advice.